Literature DB >> 20803020

[Mixed corneal dystrophy].

C Lange1, C Auw-Hädrich, D Böhringer, M Andres, K U Loeffler, T Reinhard.   

Abstract

Clinical features of Fuchs' corneal endothelial dystrophy combined with lattice dystrophy were found in an 81-year-old patient who had been treated with anti-inflammatory phosphate-rich eye drops. Histological analysis of the corneal button revealed Fuchs' corneal endothelial dystrophy, no evidence of lattice dystrophy but calcium deposits in the deep corneal stroma. This case demonstrates that calcium deposits can be incorporated in a grid-like pattern mimicking lattice dystrophy and supports the cautious use of phosphate-containing eye drops in the presence of chronic blepharoconjunctivitis and epithelial keratopathy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20803020     DOI: 10.1007/s00347-010-2231-7

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  5 in total

1.  Lattice dystrophy of the cornea. A clinical and microscopic study.

Authors:  A J DARK; D S THOMSON
Journal:  Br J Ophthalmol       Date:  1960-05       Impact factor: 4.638

Review 2.  Fuchs' endothelial dystrophy of the cornea.

Authors:  A P Adamis; V Filatov; B J Tripathi; R C Tripathi
Journal:  Surv Ophthalmol       Date:  1993 Sep-Oct       Impact factor: 6.048

3.  Phosphate concentration in ophthalmic corticoid preparations.

Authors:  W Bernauer; M A Thiel; K M Rentsch
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-03-21       Impact factor: 3.117

4.  Classic lattice corneal dystrophy associated with monoclonal gammopathy after exclusion of a TGFBI mutation.

Authors:  Khairidzan M Kamal; Sylvia A Rayner; Michael C Chen; Anthony J Aldave
Journal:  Cornea       Date:  2009-01       Impact factor: 2.651

5.  Corneal calcification following intensified treatment with sodium hyaluronate artificial tears.

Authors:  W Bernauer; M A Thiel; M Kurrer; A Heiligenhaus; K M Rentsch; A Schmitt; C Heinz; A Yanar
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.